Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.5.1. Volume Price Analysis
1.5.1.1. Approach 1: Volume Price Analysis
1.6. Data Validation & Publishing
1.7. Global Market: CAGR Calculation
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Non-Magnetic Wheelchair Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing geriatric population
3.3.1.2. Growing prevalence of physiological and neurological diseases
3.3.1.3. Increasing installations of imaging modalities such as magnetic resonance imaging (MRI).
3.3.2. Market restraint analysis
3.3.2.1. Stringent regulatory rule for providers
3.3.2.2. High-cost variability across regions and limited manufacturer presence
3.4. Business Environment Analysis
3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.4.2. Porter’s Five Forces Analysis
3.4.3. COVID-19 Impact Analysis
Chapter 4. Non-Magnetic Wheelchair Market: Patient Weight Business Analysis
4.1. Non-Magnetic Wheelchair Market: Patient Weight Movement & Market Share Analysis, 2023 & 2030
4.2. Below 100 kg
4.2.1. Below 100 kg Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.3. 100 kg to 150 kg
4.3.1. 100 kg to 150 kg Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4. Above 150 kg
4.4.1. Above 150 kg Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 5. Non-Magnetic Wheelchair Market: Magnetic Field Strength Business Analysis
5.1. Non-Magnetic Wheelchair Market: Magnetic Field Strength Movement & Market Share Analysis, 2023 & 2030
5.2. Up to 3T
5.2.1. Up to 3T Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 – 2030 (USD Million)
5.3. Up to 7T
5.3.1. Up to 7T Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 6. Non-Magnetic Wheelchair Market: End-use Business Analysis
6.1. Non-Magnetic Wheelchair Market: End-use Movement & Market Share Analysis, 2023 & 2030
6.2. Hospitals
6.2.1. Hospitals Market Estimates and Forecasts, 2018 – 2030 (USD Million)
6.3. Outpatient Facilities
6.3.1. Outpatient Facilities Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 7. Non-Magnetic Wheelchair Market: Regional Business Analysis
7.1. Regional Market Snapshot
7.2. Market Share Analysis by Country, 2023
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. MEA
7.3. North America
7.3.1. North America Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. U.S. Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.3.2.2. Key Country Dynamics
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.3. Canada
7.3.3.1. Canada Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.3.3.2. Key Country Dynamics
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.4. Europe
7.4.1. Europe Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Germany Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.4.2.2. Key Country Dynamics
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.3. UK
7.4.3.1. UK Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.4.3.2. Key Country Dynamics
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.4. France
7.4.4.1. France Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.4.4.2. Key Country Dynamics
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.5. Italy
7.4.5.1. Italy Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.4.5.2. Key Country Dynamics
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.6. Spain
7.4.6.1. Spain Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.4.6.2. Key Country Dynamics
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.7. Denmark
7.4.7.1. Denmark Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.4.7.2. Key Country Dynamics
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.8. Sweden
7.4.8.1. Sweden Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.4.8.2. Key Country Dynamics
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.9. Norway
7.4.9.1. Norway Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.4.9.2. Key Country Dynamics
7.4.9.3. Competitive Scenario
7.4.9.4. Regulatory Framework
7.5. Asia Pacific
7.5.1. Asia Pacific Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Japan Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.5.2.2. Key Country Dynamics
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.3. China
7.5.3.1. China Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.5.3.2. Key Country Dynamics
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.4. India
7.5.4.1. India Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.5.4.2. Key Country Dynamics
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.5. South Korea
7.5.5.1. South Korea Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.5.5.2. Key Country Dynamics
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.6. Australia
7.5.6.1. Australia Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.5.6.2. Key Country Dynamics
7.5.6.3. Competitive Scenario
7.5.6.4. Regulatory Framework
7.5.7. Thailand
7.5.7.1. Thailand Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.5.7.2. Key Country Dynamics
7.5.7.3. Competitive Scenario
7.5.7.4. Regulatory Framework
7.6. Latin America
7.6.1. Latin America Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Brazil Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.6.2.2. Key Country Dynamics
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.3. Mexico
7.6.3.1. Mexico Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.6.3.2. Key Country Dynamics
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.4. Argentina
7.6.4.1. Argentina Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.6.4.2. Key Country Dynamics
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.7. MEA
7.7.1. MEA Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.7.2. South Africa
7.7.2.1. South Africa Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.7.2.2. Key Country Dynamics
7.7.2.3. Competitive Scenario
7.7.2.4. Regulatory Framework
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.7.3.2. Key Country Dynamics
7.7.3.3. Competitive Scenario
7.7.3.4. Regulatory Framework
7.7.4. UAE
7.7.4.1. UAE Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.7.4.2. Key Country Dynamics
7.7.4.3. Competitive Scenario
7.7.4.4. Regulatory Framework
7.7.5. Kuwait
7.7.5.1. Kuwait Non-Magnetic Wheelchair Market, 2018 – 2030 (USD Million)
7.7.5.2. Key Country Dynamics
7.7.5.3. Competitive Scenario
7.7.5.4. Regulatory Framework
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Profiles/Listing
8.3.1. GF Health Products, Inc.
8.3.1.1. Overview
8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Magmedix Inc.
8.3.2.1. Overview
8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. MRIequip.com
8.3.3.1. Overview
8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Newmatic Medical
8.3.4.1. Overview
8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. AliMed
8.3.5.1. Overview
8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Innovative Products Unlimited, Inc.
8.3.6.1. Overview
8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Nanning Hhao Technology Co., Ltd
8.3.7.1. Overview
8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Matsunaga
8.3.8.1. Overview
8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Hebei Webian Medical Instrument Co., Ltd
8.3.9.1. Overview
8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Jiangsu Rooe Medical Technology Co., Ltd
8.3.10.1. Overview
8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
Table 1 List of abbreviations
Table 2 List of secondary sources